Showing posts with label Bill Gates. Show all posts
Showing posts with label Bill Gates. Show all posts

Friday, April 15, 2011

Foundation Activities, Vaccines and more...

These are the largest private global health foundations exerting inordinate influence on public health policy--those policies favor Big Pharma and their own corporate interests and endowment portfolios.
Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed?  by David Stuckler, Sanjay Basu, and Martin McKee, is a groundbreaking article in PLoS Medicine, illuminating the shadows that blur major conflicts of interest in the public health arena.

The article lifts the veil that hides an intricate web of direct and, more importantly, the indirect interconnected financial ties between private, tax-exempt foundations that are major funders of global health, and commercial corporations. Such relationships cannot but influence a foundation's agenda and funding decisions.
  
By "following the money," the authors found that "despite the existence of policies explicitly designed to mitigate potential conflicts of interest, the boundaries between foundations, their investments, and their parent corporations or private funders can become blurred. Often, directors of the boards of foundations also sit on the board of private corporations,
adopting multiple roles."

The authors  conducted a case study using data about the networks, activities, and funding patterns of the Bill & Melinda Gates Foundation, Ford Foundation, W. K. Kellogg Foundation, Robert Wood Johnson Foundation, and Rockefeller Foundation.

These are the largest private global health foundations exerting inordinate influence on public health policy--those policies favor Big Pharma and their own corporate interests and endowment portfolios.

Read more... http://www.ahrp.org/cms/content/view/799/9/

Stay tuned for a follow-up about a controversy involving a Gates Foundation-supported project--a market expansion strategy for increasing profits for vaccine manufacturers...

Jan 29, 2010
The depopulation plan is supported by the world's wealthiest people, including Bill Gates, who admittedly funds vaccinations to reduce global populations by 10-15%. Leading population planners and economic developers advance identical ...
Oct 11, 2007
Research into a vaccine for AIDS, which is devastating in parts of southern Africa, got a boost following a 100 million dollar (70.6 million euro) initiative launched by the Bill and Melinda Gates Foundation. ...
Feb 11, 2011
PLEASE remember this when you are listening to Bill Gates' current PR spots for vaccines. Gates has publicly stated that vaccines are good for population control. In 1926 the AMA announced it was aware of neurological damage caused by ...
Nov 03, 2008
Bill Gates' foundation recently awarded a grant to a Japanese scientist who hopes to engage mosquitoes in the vaccination of everyone. When I read the story about these awards I wondered what kind of a crazy idea this is, because just ...

Saturday, August 28, 2010

AG Money: Gates and Monsanto

Gates Foundation underwrites vaccine insanity and now GMO Food, Weed overgrowth -
Well, well, well. It's about time. Kind of like when Fox News gave $1 million in campaign contributions to Republicans. It wasn't exactly a secret before, but now it's official. The Gates Foundation just bought a whopping 500,000 shares of Monsanto stock.Now, there's nothing wrong with buying stock. My parents hold lots of BP stock, and they are hardly guilty of dumping the 4.9 million barrels of oil into the Gulf. But this is one more step in a long line of actions by the Gates Foundation in which it is advocating policies and agricultural technologies that will directly benefit and profit Monsanto while screwing over the most vulnerable people on earth: hungry subsistence farmers in developing countries.
I wrote a piece recently about what happens when American industrial agriculture collides with poor, uneducated subsistence farmers in the developing world and it ain't pretty. In fact, it's tragic. It's criminal. For a corporation to prey upon such a vulnerable population for its own gain, when the result is the starvation, continued impoverishment, or loss of land and lifestyle of the poor.
Perhaps Gates thinks he is doing something good for the world with his advocacy of biotechnology and industrial agriculture. No doubt all of the executives from Monsanto and other biotech and chemical companies tell him that every day. He should instead listen to the 400 scientists who spent 3 years performing the most comprehensive study of agricultural knowledge, science, and technology in the history of the world, the IAASTD report. The report recommends agroecology - what many in the U.S. would refer to as "organics" (even though the term is more nuanced than that).

http://www.lavidalocavore.org/diary/3953/gates-foundation-puts-its-money-where-its-mouth-is

GATES FOUNDATION INVESTS IN MONSANTO
 
Both will profit at expense of small-scale African farmers
Seattle, WA - Farmers and civil society organizations around the world are outraged by the recent discovery of further connections between the Bill and Melinda Gates Foundation and agribusiness titan Monsanto. Last week, a financial website published the Gates Foundation's investment portfolio, including 500,000 shares of Monsanto stock with an estimated worth of $23.1 million purchased in the second quarter of 2010 (see the filing with the Securities and Exchange Commission). This marks a substantial increase from its previous holdings, valued at just over $360,000 (see the Foundation's 2008 990 Form).
"The Foundation's direct investment in Monsanto is problematic on two primary levels," said Dr. Phil Bereano, University of Washington Professor Emeritus and recognized expert on genetic engineering. "First, Monsanto has a history of blatant disregard for the interests and well-being of small farmers around the world, as well as an appalling environmental track record. The strong connections to Monsanto cast serious doubt on the Foundation's heavy funding of agricultural development in Africa and purported goal of alleviating poverty and hunger among small-scale farmers. Second, this investment represents an enormous conflict of interests."
Monsanto has already negatively impacted agriculture in African countries. For example, in South Africa in 2009, Monsanto's genetically modified maize failed to produce kernels and hundreds of farmers were devastated. According to Mariam Mayet, environmental attorney and director of theAfrica Centre for Biosafety in Johannesburg, some farmers suffered up to an 80% crop failure. While Monsanto compensated the large-scale farmers to whom it directly sold the faulty product, it gave nothing to the small-scale farmers to whom it had handed out free sachets of seeds. "When the economic power of Gates is coupled with the irresponsibility of Monsanto, the outlook for African smallholders is not very promising," said Mayet. Monsanto's aggressive patenting practices have also monopolized control over seed in ways that deny farmers control over their own harvest, going so far as to sue-and bankrupt-farmers for "patent infringement."
News of the Foundation's recent Monsanto investment has confirmed the misgivings of many farmers and sustainable agriculture advocates in Africa, among them the Kenya Biodiversity Coalition, who commented, "We have long suspected that the founders of AGRA-the Bill and Melinda Gates Foundation-had a long and more intimate affair with Monsanto." Indeed, according to Travis English, researcher with AGRA Watch, "The Foundation's ownership of Monsanto stock is emblematic of a deeper, more long-standing involvement with the corporation, particularly in Africa." In 2008, AGRA Watch, a project of the Seattle-based organization Community Alliance for Global Justice, uncovered many linkages between the Foundation's grantees and Monsanto. For example, some grantees (in particular about 70% of grantees in Kenya) of the Alliance for a Green Revolution in Africa (AGRA)-considered by the Foundation to be its "African face"-work directly with Monsanto on agricultural development projects. Other prominent links include high-level Foundation staff members who were once senior officials for Monsanto, such as Rob Horsch, formerly Monsanto Vice President of International Development Partnerships and current Senior Program Officer of the Gates Agricultural Development Program.
Transnational corporations like Monsanto have been key collaborators with the Foundation and AGRA's grantees in promoting the spread of industrial agriculture on the continent. This model of production relies on expensive inputs such as chemical fertilizers, genetically modified seeds, and herbicides. Though this package represents enticing market development opportunities for the private sector, many civil society organizations contend it will lead to further displacement of farmers from the land, an actual increase in hunger, and migration to already swollen cities unable to provide employment opportunities. In the words of a representative from the Kenya Biodiversity Coalition, "AGRA is poison for our farming systems and livelihoods. Under the philanthropic banner of greening agriculture, AGRA will eventually eat away what little is left of sustainable small-scale farming in Africa."
A 2008 report initiated by the World Bank and the UN, the International Assessment of Agricultural Knowledge, Science and Technology for Development (IAASTD), promotes alternative solutions to the problems of hunger and poverty that emphasize their social and economic roots. The IAASTD concluded that small-scale agroecological farming is more suitable for the third world than the industrial agricultural model favored by Gates and Monsanto. In a summary of the key findings of IAASTD, the Pesticide Action Network North America (PANNA) emphasizes the report's warning that "continued reliance on simplistic technological fixes-including transgenic crops-will not reduce persistent hunger and poverty and could exacerbate environmental problems and worsen social inequity." Furthermore, PANNA explains, "The Assessment's 21 key findings suggest that small-scale agroecological farming may offer one of the best means to feed the hungry while protecting the planet."
The Gates Foundation has been challenged in the past for its questionable investments; in 2007, the L.A. Times exposed the Foundation for investing in its own grantees and for its "holdings in many companies that have failed tests of social responsibility because of environmental lapses, employment discrimination, disregard for worker rights, or unethical practices." The Times chastised the Foundation for what it called "blind-eye investing," with at least 41% of its assets invested in "companies that countered the foundation's charitable goals or socially-concerned philosophy."
Although the Foundation announced it would reassess its practices, it decided to retain them. As reported by the L.A. Times, chief executive of the Foundation Patty Stonesifer defended their investments, stating, "It would be naïve...to think that changing the foundation's investment policy could stop the human suffering blamed on the practices of companies in which it invests billions of dollars." This decision is in direct contradiction to the Foundation's official "Investment Philosophy", which, according to its website, "defined areas in which the endowment will not invest, such as companies whose profit model is centrally tied to corporate activity that [Bill and Melinda] find egregious. This is why the endowment does not invest in tobacco stocks."
More recently, the Foundation has come under fire in its own hometown. This week, 250 Seattle residents sent postcards expressing their concern that the Foundation's approach to agricultural development, rather than reducing hunger as pledged, would instead "increase farmer debt, enrich agribusiness corporations like Monsanto and Syngenta, degrade the environment, and dispossess small farmers." In addition to demanding that the Foundation instead fund "socially and ecologically appropriate practices determined locally by African farmers and scientists" and support African food sovereignty, they urged the Foundation to cut all ties to Monsanto and the biotechnology industry.
AGRA Watch, a program of Seattle-based Community Alliance for Global Justice, supports African initiatives and programs that foster farmers' self-determination and food sovereignty. AGRA Watch also supports public engagement in fighting genetic engineering and exploitative agricultural policies, and demands transparency and accountability on the part of the Bill and Melinda Gates Foundation and AGRA.

Thursday, April 29, 2010

Bill Gates Needs a Few Lessons

ORIGINALLY POSTED: 1/29/10

Ten Billion dollars will go a very long way to improve health if only it were used to provide super nutrition and supplements that are known to be superior sources of health.

Vaccines just do not prove effective over time and the science proves it.  The Rotavirus vaccine was proven very problematic as has been the pneumonia vaccine.  The AIDS vaccine development was a flop!

Focusing on vaccines really provides welfare to the pharmaceutical industry, little for human beings in need of good food and supplements to help them rebuild their nutritional status.  A few armed guards are needed as well to insure that these life saving items reach the people.

Malaria can be both prevented and treated with supplements and netting.

Drug resistant TB is cured with garlic.  Four vitamins prevent HIV from becoming AIDS.

Bill and Melinda must still be in their wonderland of ignorance, fueled by WHO and Big PhRMA propaganda..
Bill and Melinda Gates announced plans Friday to invest $10 billion in the fight against a number of illnesses including AIDS and said the record donation could save nearly nine million lives.

Speaking at the World Economic Forum in Davos, Switzerland, they said the 10-year program will focus on vaccines for AIDS, tuberculosis, rota virus and pneumonia.

"We must make this the decade of vaccines," said Bill Gates.
http://www.cnn.com/2010/BUSINESS/01/29/davos.bill.gates.donates/index.html
Profitable Depopulation Plot Links JP Morgan-Chase/Goldman Sachs To Vaccination Contamination and BigPharma Corruption
By Dr. Leonard Horowitz, 4-29-10
COURTESY: RENSE.COM

A medical investigation into suspicious outbreaks and propaganda used to sell drugs and vaccines has exposed investment bankers at JP Morgan-Chase (JPMC) and Goldman Sachs (GS) for plotting to shock/stress, frighten, poison, and kill billions of people most profitably--pharmaceutically--according to the Editor-in-Chief of Medical Veritas journal.

While researching a powerful Partnership for New York City (PFNYC), uniting Wall Street's wealthiest industrialists, Harvard-trained public health expert, Dr. Leonard Horowitz, and investigative journalist, Sherri Kane, discovered shocking evidence of a conspiracy to commit global genocide by generating diseases and death to advance profitable pharmaceutical depopulation.

Population planners at the highest levels of government and industry conspired to spread diseases, vaccines, drugs, and death most profitably, according to research published in the latest issue of Medical Veritas.

In a related Special Report posted on YouTube, Dr. Horowitz urged humanitarian organizations and activist groups worldwide to issue investigations, alerts, civil complaints, and criminal charges to stop the pharmaceutical depopulation plot because it risks genetic inheritance, new pandemics, and the possible extinction of the human race.

"Corruption in the drug industry is rampant and transparent," Dr. Horowitz explains. "Investment bankers at JPMC and GS, who acquired controlling interests in the largest drug firms during mergers and acquisitions, have placed 'depopulation' near the top of their list of geopolitical priorities. Their depopulation agents are now in top positions of government, finance, and industry.

The depopulation plan is supported by the world's wealthiest people, including Bill Gates, who admittedly funds vaccinations to reduce global populations by 10-15%. Leading population planners and economic developers advance identical plans to cull the world's population to 1 billion.

"Killing 6-out-of-7 people globally, most profitably, requires planning and an unprecedented conspiracy to commit genocide by applying advances in genetic biotechnologies exclusively available and affordable to drug companies controlled by the investment bankers," Dr. Horowitz adds.

The doctor points to the fact that US Treasury Department officials previously operated JPMC and GS on behalf of majority stock holders and their partners in pharmaceutical companies heavily represented in the PFNYC and the trade organizations that negotiate multi-billion dollar government purchases of drugs and vaccines.

Researchers, including vaccination contamination expert Dr. Viera Scheibner, reports in the current issue of Medical Veritas that polio virus vaccines are produced in African green monkey kidney cell cultures routinely contaminated with transmissible cancer viruses.

By reviewing drug company patents, Dr. Horowitz learned that the makers of H1N1 swine flu and rotavirus vaccines use the same cultures risking recombinations, genetic mutations, and unstoppable transmissions of deadly agents threatening new pandemics.

"This best explains why public health officials are preparing for vaccine-transmitted H1N1s cloned in monkey cells to recombine with bird H5N1s currently circulating. This threatening and most deadly recombination of flu viruses, officials herald may happen in the Fall," Dr. Horowitz warned.

Besides the inadequacies of safety testing new vaccines without using placebo controls, it is this issue of reliability of information that concerns more than half of the medical physicians polled since they became aware that the entire medical industry has been hijacked by Wall Street's pharmaceutical profiteers. Now they are learning from famous people, like Gates, that the world's wealthiest people are administering vaccinations for depopulation.

"I love vaccines," Gates stated at a TED conference in February, 2010, while lecturing on ways to reduce global populations to stem environmental pollution.

The links between the directors of major drug companies, mainstream media moguls, and investment bankers at JPMC and GS are so obvious and incriminating, and the dispersion of unsafe vaccines so common and disturbing, only profitable depopulation as a planned outcome of pharmaceutical investments can explain the current situation.

"Complete censorship was the only option officials have had to prevent a meltdown in public opinion about medicine and the pharmaceutical industry," said Ingri Cassel, a leading vaccine risk awareness activist. "This explains why news of this vaccination depopulation plan has been neglected by the special-interest-influenced media."

Investigating conflicting pharmaceutical interests influencing news coverage, Sherri Kane, previously a writer for FOX News in Los Angeles, learned that the majority shareholders in FOX, TimeWarner, News Corp., and the Wall Street Journal, are heavily invested in GlaxoSmithKlein and Merck's CSL Laboratories, both makers of risky drugs and vaccines.

Lloyd Blankfein, the CEO of Goldman Sachs, became a major shareholder in AstraZeneca following his direction of the company's acquisition of the H1N1 FluMist maker, MedImmune. Blankfein has also leveraged ABC-Disney following their merger with money he raised through GS investors. This resulted in Dr. Oz's heavy promotion of H1N1 vaccines on ABC last year, when officials learned that the vast majority of Americans were unwilling to risk the exposure.

Rupert Murdoch and Lloyd Blankfein co-chair the PFNYC, founded by CHASE principal, World Bank ambassador, and America's leading energy industrialist and medical monopolist, David Rockefeller. The PFNYC was chartered by the Royal Family of England--a majority share holder in General Electric--the world's largest company--that controls NBC/Universal/Comcast, and MSNBC with Bill Gates.

The PFNYC was pledged to play a central role in reconstructing Ground Zero following the 9/11 attacks, according to Kathryn Wylde, President & CEO of the Partnership and current Director of The Federal Reserve Bank of New York. The organization compiled the economic report on the damage done, advanced financial plans for reconstructing the World Trade Center, and advised leading financiers regarding reconstruction investments.

According to 911-Truth movement directors, Wylde and other members of the PFNYC are implicated in the treasonous attacks that scientific evidence says involved thermitic explosives used in controlled demolitions.

These allegations and PFNYC connections to 9/11 events implicating investment bankers at Goldman Sachs are additionally scrutinized in a new feature-length film produced by Dr. Horowitz. PHARMAWHORES: The SHOWTIME Sting of Penn & Teller premieres in theaters across North America this summer. (Quicktime and MP-4 downloadable versions are available through PharmaWhores.com.)

The PFNYC is co-directed by Jeffrey B. Kindler, the Chairman and CEO of Pfizer--the world's largest drug company. Kindler stewards Pfizer through multi-billion dollar acquisitions also involving JPMC and GS financing.

The Pharmaceutical Research and Manufacturers of America (PhRMA), the drug industry's main trade organization, is also directed by Kindler. PhRMA officials engage White House and Pentagon officials in private negotiations determining pricing for stockpiles of drugs and vaccines.

Dr. Horowitz views this covert administration of multi-billion dollar pharmaceutical contracts as symptomatic of the industry's corruption. The "corporate shell game" is played using mergers and acquisitions directed by the same people. Their creation of the PhRMA trade organization provides the illusion of their legitimacy and fair competition. Price fixing occurs behind closed doors, explaining why prices vary so widely internationally.

Another gross example of corrupt government pharmawhores sucking Wall Street's slime, is Congressman Henry Waxman's (D-CA) treason against the American people for sneaking dietary supplement regulation language into 'The Wall Street Reform and Consumer Protection Act of 2009,' (H.R. 4173).

For years, Waxman has attempted to pass legislation restricting consumer access to nutritional supplements on behalf of BigPharma. The FDA, largely controlled by BigPharma, contends regulating vitamins, minerals, herbs, homeopathics, oils, colloidal silvers, and more natural products protects consumers.

During health care reform negotiations with PhRMA, Waxman feigned concern that drug companies were driving too hard a "bargain" on pharmaceutical prices, but still voted in favor of the cartel's freedom to set their own limits.

Most telling and ironic, PhRMA's official negotiator to whom Waxman complained, "PhRMA should contribute more than PhRMA wants to contribute," was Billy Tauzin, the former congressman who held Waxman's job as chair of the Energy and Commerce committee.

Natural Health News is proud to be a contributing correspondent with the Rense News Network

Wednesday, April 1, 2009

$33M for TB

I have pointed to this research for many years, and I'll take the opportunity again to report this.

Garlic has proven in microbiology studies to effectively treat drug resistant TB.

It would appear to me that an inexpensive approach to this seemingly major public health problem could be promptly implemented for much less that the $33M Bill Gates just donated to China for more studies and an attempt to come up with a new drug, and some patient tracking.

Gee Bill are you really serious about this and some other health issues you are funding?

Gates Foundation, China announce $33M TB project

Wednesday, November 5, 2008

Merck vaccine trail increased infection risk

This article points out vaccine failure. I reported on this blog at the time this report was first made. Now there is room for an update.

This experimental HIV vaccine was a Merck product, not unlike the Gardasil vaccine that is known to have caused death and higher risk of disease, without real promise of effectiveness, and no long term studies.

With advertising and marketing Merck and the FDA have made a killing of sorts, at the bank. This might be a good analogy for those of us that keep trying to explain that vaccines aren't all they are built up to be. They do make people sick.

And here's my opportunity to make another plug for the trial I'd like to run with supplements to show they can stop the conversion of HIV to AIDS.

If Bill Gates won't give me a grant perhaps Merck will. Just wish Sir Elton would read this, I'd like his money better. William and Harry might come through so we can dedicate this to their Mum.
Experimental HIV vaccine may have increased infection risk
Mon Nov 3, 2008
WASHINGTON (AFP) – Trials of a once-promising experimental HIV vaccine were cut short in 2007 because the drug may have increased the likelihood of HIV infection rather than preventing it, according to a new study.

The HIV-1 vaccine, which raised hopes in the fight against AIDS as it was being developed by US pharmaceutical giant Merck and Co., was undergoing second stage trials when the problem was discovered in September 2007, said researchers at the Montpellier Institute of Molecular Genetics in France.

The vaccine relied on a modified form of a common cold virus -- Adenovirus 5 (Ad5) -- to carry elements of HIV (Human immunodeficiency virus) into the body.

The smaller HIV parts, the Merck trials contended, would trigger the human immune system to start fighting off later infection with the virus.

One of main worries about the approach was that widespread immunity to the vaccine might cause the drug to be rejected by the body before an effective anti-HIV response could develop.

But three years after the first trial, researchers discovered that more of the vaccine recipients who had prior immunity to the Ad5 virus had been infected with HIV than those not exposed to the vaccine, according to the study, published online in the Journal of Experimental Medicine.

The presence of long-lasting antibodies specifically catering to the Ad5 virus, generated during natural infections with the common cold, could have altered the response to the HIV vaccine, the study said.

HIV infection spread through cell cultures three times faster in the presence of antibodies from individuals immune to the Ad5 virus, because the HIV virus came in contact with more of its preferred "T" cells -- prompted to grow by the vaccine -- to infect.

The study said the vaccine reached the second phase of its trials because primates, used in the first phase, do not naturally come into contact with the human common cold, so the problem went unrecognized.

The vaccine prototype was tested on 700 HIV-negative persons in five hospitals in South Africa between February and September 2007, in the first clinical HIV trial of its magnitude ever conducted in Africa.

Meanwhile, tests had been conducted since 2004 in the United States, Australia, Peru, Brazil and Puerto Rico.

HIV can lead to acquired immunodeficiency syndrome (AIDS).

According to the World Health Organization, 33 million people around the world are infected with the AIDS virus, mostly in the sub-Sahara Africa.

Some two million people died worldwide of AIDS in 2007.

Copyright © 2008 Agence France Presse.

Monday, November 3, 2008

AIDS treatment should be started sooner

Bill Gates' foundation recently awarded a grant to a Japanese scientist who hopes to engage mosquitoes in the vaccination of everyone.

When I read the story about these awards I wondered what kind of a crazy idea this is, because just like the fluoridation of municipal water supplies, the concept overlooks informed consent, practicing medicine without a license, and not taking adverse reactions or allergy into consideration.

With AIDS, I am not denying that treatment should start as early as possible, but I'd rather get a grant from Gates to run a trial of my suggestion to provide a set of four nutritional supplements to people with HIV, in an effort to show that this pack prevent the progression from HIV to AIDS.

So Bill, I know I won't have any trouble locating a test group for my project. I'm sure to get cooperation of a supplement company to provide the items needed in the amount needed. Then we can support this research for many more people for a longer time period than in a lab, and most likely get real outcomes and a ton of better health for everyone involved.

Of course if this is too logical for you, I'm sure Bono or some one else would bbe willing to work on my team.
AIDS treatment should be started sooner, study saysMonday, October 27, 2008 By Marilynn Marchione

ASSOCIATED PRESS
WASHINGTON -- People who have the AIDS virus should start drug treatments sooner than current guidelines recommend, suggests a large new study that could change the care of hundreds of thousands of Americans.

The study found that delaying treatment until a patient's immune system is badly damaged nearly doubles the risk of dying in the next few years compared with patients whose treatment started earlier.

Doctors have thought it would be better to spare patients the side effects of AIDS drugs as long as possible.

"The data are rather compelling that the risk of death appears to be higher if you wait than if you treat," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which helped pay for the study. The institute is a division of the National Institutes of Health.

If the results prompt doctors to change practice, as Fauci and other AIDS specialists predict, several hundred thousand Americans who are not taking AIDS drugs now would be advised to start.

The study was reported yesterday at an infectious-diseases conference in Washington.

About 56,300 Americans are newly infected with HIV each year. The virus ravages T-cells -- "helper cells" of the immune system that fight off germs. Once that happens, people can fall prey to a host of diseases that prove fatal.

Powerful drug combinations available since the mid-1990s have transformed HIV infection into a manageable chronic condition rather than the death sentence it once was. But the drugs can cause heart and cholesterol problems, diarrhea, nausea and other side effects. They also must be taken faithfully, or resistance develops and the drugs stop working.

That is why guidelines by the government and the International AIDS Society recommend that patients who are not yet having AIDS symptoms delay starting on the drugs until their T-cell counts fall below 350 per cubic millimeter of blood (healthy people have more than 800).

"There was this thinking, maybe the drugs were worse than the disease. If you could wait as long as you possibly could wait, you would have fewer side effects," said Dr. Robert Schooley, infectious-diseases chief at the University of California, San Diego.

The new study is the largest to look at whether that advice is sound. Researchers led by Dr. Mari Kitahata of the University of Washington in Seattle pooled information on 8,374 people in the United States and Canada with T-cell counts of 351 to 500 from 1996 to 2006.

About 30 percent started taking AIDS drugs right away; the rest waited until their T-cell counts fell below 350, as guidelines recommend.

"We found a 70 percent improvement in survival for patients who initiated therapy between 350 and 500" compared with those who waited, Kitahata said.

Two other recent studies found that people who start taking AIDS drugs while their T-cell count is above 350 have a better chance of getting their count back to normal than those who start later. Another key study found that briefly interrupting treatment to give patients "drug holidays" puts them at grave risk.

"These studies have all shown the same thing -- that we were starting too late" and need to keep treatment going once it starts, Schooley said. He helped write the AIDS society guidelines and consults for several companies that make AIDS drugs.

The bigger problem is that as many as a third of people diagnosed with HIV only discover they are infected after their T-cell counts already have fallen below 350 and they have serious complications.

"People are still being tested and identified way too late," said Dr. Daniel Kuritzkes, an AIDS specialist at Brigham and Women's Hospital in Boston. He said the new study shows how important it is to test and find people sooner.

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Macys Printable Coupons